种族或族裔是否影响子痫前期的起源、病理生理及结局?一项专家文献综述
子痫前期总体患病率3%至5%,但非西班牙裔黑人及美洲印第安或阿拉斯加原住民女性负担不成比例地高;种族是社会建构而非生物学构造,现有差异研究多集中于白人与非西班牙裔黑人比较,探讨种族与病理生理及预防的研究有限,未来需纳入多层次框架研究种族主义的影响。
要点
- 子痫前期患病率3%至5%,非西班牙裔黑人和美洲印第安或阿拉斯加原住民女性受累比例不成比例地高。
- 种族是社会建构且常为自我认定,不同场景间可变,不能作为生物学构造用于临床决策。
- 实施低剂量阿司匹林补充后,西班牙裔女性复发性子痫前期从76.4%降至49.6%(P<.001),非西班牙裔黑人女性13.7 vs 18.1(P=.252)无差异。
核心结论
- 子痫前期负担在人群中分布不均,少数族裔群体受累不成比例地高,但阐明种族和族裔差异原因的研究有限。
- 种族是社会建构,不能作为生物学构造用于生物医学研究和临床决策,在临床决策中使用种族可能加剧健康结局差异。
- 未来研究纳入美国国立少数族裔健康与健康差异研究所的多层次框架、特别是探究种族主义对该病负担的作用,可能有助于寻找减少少数族裔子痫前期不成比例负担的有效策略。
研究设计与样本
- 专家文献综述,检索并汇总有关种族或族裔在子痫前期起源、病理生理和结局中作用的现有文献。
主要发现
- 子痫前期患病率报告为3%至5%,非西班牙裔黑人和美洲印第安或阿拉斯加原住民女性被广泛报告受累不成比例地高。
- 人类群体遗传结构研究继续发现种族组内的变异多于组间变异。
- 现有差异数据大多比较白人与非西班牙裔黑人女性,评估亚洲、美洲印第安或阿拉斯加原住民或混血女性结局的研究样本量较少。
- 肥胖、糖尿病和慢性高血压等子痫前期公认临床危险因素不成比例地影响非西班牙裔黑人、美洲印第安或阿拉斯加原住民和西班牙裔人群。
- 在不同种族或族裔群体女性子痫前期临床危险因素可比的情况下,解决可改变危险因素并未发现对所有女性具有相同保护效果。
关键数值与推荐
- 美国预防服务工作组推荐低剂量阿司匹林用于预防子痫前期。
- 一项基于人群的研究发现,实施低剂量阿司匹林补充后子痫前期复发存在种族和族裔差异:西班牙裔女性复发性子痫前期从76.4%降至49.6%(P<.001),非西班牙裔黑人女性为13.7 vs 18.1(P=.252),无差异。
- 载脂蛋白L1等若干遗传变异已被确定为可能的风险修饰因素。
- 胎盘形成和发育异常、免疫因素、血管改变和炎症均已被认定参与子痫前期的病理生理。
临床怎么用
- 原文未据此给出推荐。
局限性
- 阐明子痫前期种族和族裔差异原因的研究有限。
- 种族常为自我认定、在不同场景间可变且未能涵盖亚组。
- 大多数现有差异数据仅比较白人女性和非西班牙裔黑人女性。
- 评估亚洲、美洲印第安或阿拉斯加原住民或混血女性结局的研究样本量较少。
- 探讨种族与子痫前期病理生理及预防的研究较少,尽管多方尝试仍未确定该病的遗传基础。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The burden of preeclampsia, a substantial contributor to perinatal morbidity and mortality, is not born equally across the population. Although the prevalence of preeclampsia has been reported to be 3% to 5%, racial and ethnic minority groups such as non-Hispanic Black women and American Indian or Alaskan Native women are widely reported to be disproportionately affected by preeclampsia. However, studies that add clarity to the causes of the racial and ethnic differences in preeclampsia are limited. Race is a social construct, is often self-assigned, is variable across settings, and fails to account for subgroups. Studies of the genetic structure of human populations continue to find more variations within racial groups than among them. Efforts to examine the role of race and ethnicity in biomedical research should consider these limitations and not use it as a biological construct. Furthermore, the use of race in decision making in clinical settings may worsen the disparity in health outcomes. Most of the existing data on disparities examine the differences between White and non-Hispanic Black women. Fewer studies have enough sample size to evaluate the outcomes in the Asian, American Indian or Alaskan Native, or mixed-race women. Racial differences are noted in the occurrence, presentation, and short-term and long-term outcomes of preeclampsia. Well-established clinical risk factors for preeclampsia such as obesity, diabetes, and chronic hypertension disproportionately affect non-Hispanic Black, American Indian or Alaskan Native, and Hispanic populations. However, with comparable clinical risk factors for preeclampsia among women of different race or ethnic groups, addressing modifiable risk factors has not been found to have the same protective effect for all women. Abnormalities of placental formation and development, immunologic factors, vascular changes, and inflammation have all been identified as contributing to the pathophysiology of preeclampsia. Few studies have examined race and the pathophysiology of preeclampsia. Despite attempts, a genetic basis for the disease has not been identified. A number of genetic variants, including apolipoprotein L1, have been identified as possible risk modifiers. Few studies have examined race and prevention of preeclampsia. Although low-dose aspirin for the prevention of preeclampsia is recommended by the US Preventive Service Task Force, a population-based study found racial and ethnic differences in preeclampsia recurrence after the implementation of low-dose aspirin supplementation. After implementation, recurrent preeclampsia reduced among Hispanic women (76.4% vs 49.6%; P<.001), but there was no difference in the recurrent preeclampsia in non-Hispanic Black women (13.7 vs 18.1; P=.252). Future research incorporating the National Institute on Minority Health and Health Disparities multilevel framework, specifically examining the role of racism on the burden of the disease, may help in the quest for effective strategies to reduce the disproportionate burden of preeclampsia on a minority population. In this model, a multilevel framework provides a more comprehensive approach and takes into account the influence of behavioral factors, environmental factors, and healthcare systems, not just on the individual.
引用
- Johnson JD, Louis JM. Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature. Am J Obstet Gynecol. 2020. PMID: 32717255. doi:10.1016/j.ajog.2020.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。